Neoadjuvant PD-1 Blockade in Resectable Lung CancerPatrick M. Forde, Drew M. Pardoll, Matthew D. Hellmann et al.|New England Journal of Medicine|2018Cited by 2.1k
Transcriptional programs of neoantigen-specific TIL in anti-PD-1-treated lung cancersJustina X. Caushi, Kellie N. Smith, Taha Merghoub et al.|Nature|2021Cited by 546